Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Three-year results of renal function in liver transplant recipients on low-dose sirolimus and tacrolimus: a multicenter, randomized, controlled trial.
Mulder MB, van Hoek B, van den Berg AP, Polak WG, Alwayn IPJ, de Jong KP, de Winter BCM, Verhey-Hart E, Erler NS, den Hoed CM, Metselaar HJ. Mulder MB, et al. Among authors: van hoek b, van den berg ap. Liver Transpl. 2023 Feb 1;29(2):184-195. doi: 10.1097/LVT.0000000000000003. Epub 2023 Jan 3. Liver Transpl. 2023. PMID: 36668691 Clinical Trial.
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.
Abdelmalek MF, Humar A, Stickel F, Andreone P, Pascher A, Barroso E, Neff GW, Ranjan D, Toselli LT, Gane EJ, Scarola J, Alberts RG, Maller ES, Lo CM; Sirolimus Liver Conversion Trial Study Group. Abdelmalek MF, et al. Am J Transplant. 2012 Mar;12(3):694-705. doi: 10.1111/j.1600-6143.2011.03919.x. Epub 2012 Jan 10. Am J Transplant. 2012. PMID: 22233522 Free article. Clinical Trial.
Modifying Tacrolimus-related Toxicity After Liver Transplantation Comparing Life Cycle Pharma Tacrolimus Versus Extended-released Tacrolimus: A Multicenter, Randomized Controlled Trial.
Mulder MB, van Hoek B, Polak WG, Alwayn IPJ, de Winter BCM, Darwish Murad S, Verhey-Hart E, Elshove L, Erler NS, Hesselink DA, den Hoed CM, Metselaar HJ. Mulder MB, et al. Among authors: van hoek b. Transplant Direct. 2024 Mar 12;10(4):e1612. doi: 10.1097/TXD.0000000000001612. eCollection 2024 Apr. Transplant Direct. 2024. PMID: 38481963 Free PMC article.
Liver Transplantation.
Kappe NN, Stolk J, van Hoek B. Kappe NN, et al. Among authors: van hoek b. N Engl J Med. 2024 Jan 25;390(4):387. doi: 10.1056/NEJMc2314292. N Engl J Med. 2024. PMID: 38265663 No abstract available.
Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial.
Stoelinga AEC, Tushuizen ME, van den Hout WB, Girondo MDMR, de Vries ES, Levens AD, Moes DAR, Gevers TJG, van der Meer S, Brouwer HT, de Jonge HJM, de Boer YS, Beuers UHW, van der Meer AJ, van den Berg AP, Guichelaar MMJ, Drenth JPH, van Hoek B; Dutch Autoimmune Hepatitis Group. Stoelinga AEC, et al. Among authors: van hoek b. Trials. 2024 Jan 17;25(1):61. doi: 10.1186/s13063-023-07832-w. Trials. 2024. PMID: 38233878 Free PMC article.
An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis.
Snijders RJALM, Stoelinga AEC, Gevers TJG, Pape S, Biewenga M, Tushuizen ME, Verdonk RC, de Jonge HJM, Vrolijk JM, Bakker SF, Vanwolleghem T, de Boer YS, Baven Pronk MAMC, Beuers U, van der Meer AJ, Gerven NMFV, Sijtsma MGM, van Eijck BC, van IJzendoorn MC, van Herwaarden M, van den Brand FF, Korkmaz KS, van den Berg AP, Guichelaar MMJ, Levens AD, van Hoek B, Drenth JPH; Dutch Autoimmune Hepatitis Working Group. Snijders RJALM, et al. Among authors: van hoek b. J Hepatol. 2024 Apr;80(4):576-585. doi: 10.1016/j.jhep.2023.11.032. Epub 2023 Dec 14. J Hepatol. 2024. PMID: 38101756 Free article. Clinical Trial.
Health-related Quality of Life and Fatigue in Liver Transplant Recipients Receiving Tacrolimus Versus Sirolimus-based Immunosuppression: Results From a Randomized Trial.
Mulder MB, Busschbach JV, van Hoek B, van den Berg AP, Polak WG, Alwayn IPJ, de Winter BCM, Verhey-Hart E, Erler NS, den Hoed CM, Metselaar HJ. Mulder MB, et al. Among authors: van hoek b. Transplantation. 2023 Dec 1;107(12):2545-2553. doi: 10.1097/TP.0000000000004619. Epub 2023 May 16. Transplantation. 2023. PMID: 38010321 Clinical Trial.
242 results